Article
SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Anticancer research - 1 Jul 2015
Winchester Danyelle, Ricks-Santi Luisel, Mason Tshela, Abbas Muneer, Copeland Robert L, Beyene Desta, Jingwi Emmanuel Y, Dunston Georgia M, Kanaan Yasmine M
Abstract excerpt
BACKGROUND/AIM: Several studies reported that patients with benign prostatic hyperplasia (BPH) experienced a 10% increased incidence of prostate cancer (PCa) after the first 5 years of diagnosis. We investigated the association between single nucleotide polymorphisms (SNPs) in the promoter of Serine Protease Inhibitor Kazal Type 1 (SPINK1) and the increased risk of BPH and PCa. MATERIALS AND METHODS: We genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
